Zungho Zun

Zungho Zun

Auto-generated profile, based on publicly available information

Zungho Zun

Department of Radiology Weill Cornell Medicine New York New York USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 November 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZZZungho Zun
Zungho Zun
GZGreg Zaharchuk
Greg Zaharchuk
NANickie Niforatos Andescavage
Nickie Niforatos Andescavage
MDMary T. Donofrio
Mary T. Donofrio
CLCatherine Limperopoulos
Catherine Limperopoulos
The placenta is a vital organ for fetal growth and development during pregnancy. Congenital heart disease (CHD) is a leading cause of morbidity and mortality in newborns. Despite the parallel development of the placenta and fetal heart early in pregnancy, very few studies suggested an association between placental dysfunction and fetal CHD. In this study, we report placental perfusion of healthy pregnancies and pregnancies complicated by fetal CHD measured using advanced fetal MRI techniques. We studied forty-eight pregnant women (31 healthy volunteers and 17 with fetal CHD) that underwent fetal MRI during their second or third trimester of pregnancy. Placental perfusion imaging was performed using velocity-selective arterial spin labeling (VSASL) and 3D image acquisition with whole-placenta coverage. In pregnancies with fetal CHD, global placental perfusion significantly decreased and regional variation of placental perfusion significantly increased with advancing gestational age; however, no such correlation was found in healthy pregnancies. Also, global placental perfusion was significantly higher in fetal CHD versus controls, in the lateral side-lying patient position versus supine, and in the posterior placental position versus anterior placental position. This study reports for the first time non-invasive whole-placenta perfusion imaging in utero. These data suggest that placental VSASL may serve as a potential biomarker of placental dysfunction in fetuses diagnosed with CHD.

12 July 2022 in Magnetic Resonance in Medicine
Verified
Journal Article
Open access
QQQin Qin
Qin Qin
DADavid C. Alsop
David C. Alsop
DBDivya S. Bolar
Divya S. Bolar
LHLuis Hernandez‐Garcia
Luis Hernandez‐Garcia
JMJames Meakin
James Meakin
TGthe ISMRMPerfusion Study Group
the ISMRMPerfusion Study Group
This review article provides an overview of the current status of velocity‐selective arterial spin labeling (VSASL) perfusion MRI and is part of a wider effort arising from the International Society for Magnetic Resonance in Medicine (ISMRM) Perfusion Study Group. Since publication of the 2015 consensus paper on arterial spin labeling (ASL) for cerebral perfusion imaging, important advancements have been made in the field. The ASL community has, therefore, decided to provide an extended perspective on various aspects of technical development and application. Because VSASL has the potential to become a principal ASL method because of its unique advantages over traditional approaches, an in‐depth discussion was warranted. VSASL labels blood based on its velocity and creates a magnetic bolus immediately proximal to the microvasculature within the imaging volume. VSASL is, therefore, insensitive to transit delay effects, in contrast to spatially selective pulsed and (pseudo‐) continuous ASL approaches. Recent technical developments have improved the robustness and the labeling efficiency of VSASL, making it a potentially more favorable ASL approach in a wide range of applications where transit delay effects are of concern. In this review article, we (1) describe the concepts and theoretical basis of VSASL; (2) describe different variants of VSASL and their implementation; (3) provide recommended parameters and practices for clinical adoption; (4) describe challenges in developing and implementing VSASL; and (5) describe its current applications. As VSASL continues to undergo rapid development, the focus of this review is to summarize the fundamental concepts of VSASL, describe existing VSASL techniques and applications, and provide recommendations to help the clinical community adopt VSASL.

6 February 2023 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
MTManuel Taso
Manuel Taso
VAVeronica Aramendía‐Vidaurreta
Veronica Aramendía‐Vidaurreta
EEErin K. Englund
Erin K. Englund
SFSusan Francis
Susan Francis
SFSuzanne Franklin
Suzanne Franklin
TGthe ISMRM Perfusion Study Group
the ISMRM Perfusion Study Group

13 February 2018 in Magnetic Resonance in Medicine
Verified
Journal Article
Closed access
PDF file
ZZZungho Zun
Zungho Zun
CLCatherine Limperopoulos
Catherine Limperopoulos

7 February 2023 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Closed access
ADAlexey V. Dimov
Alexey V. Dimov
JLJiahao Li
Jiahao Li
TNThanh Nguyen
Thanh Nguyen
Alexandra Grace RobertsAlexandra Grace Roberts
Alexandra Grace Roberts
PSPascal Spincemaille
Pascal Spincemaille
YWYi Wang
Yi Wang

20 July 2016 in Journal of Cerebral Blood Flow & Metabolism
Verified
Journal Article
Open access
WNWendy W Ni
Wendy W Ni
TCThomas Christen
Thomas Christen
JRJarrett Rosenberg
Jarrett Rosenberg
ZZZungho Zun
Zungho Zun
MMMichael E Moseley
Michael E Moseley
GZGreg Zaharchuk
Greg Zaharchuk
This study aimed to determine whether measurements of cerebrovascular reserve and oxygenation, assessed with spin relaxation rate R2′, yield similar information about pathology in pre-operative Moyamoya disease patients, and to assess whether R2′ is a better measure of oxygenation than other proposed markers, such as R2* and R2. Twenty-five pre-operative Moyamoya disease patients were scanned at 3.0T with acetazolamide challenge. Cerebral blood flow mapping with multi-delay arterial spin labeling, and R2*, R2, and R2′ mapping with Gradient-Echo Sampling of Free Induction Decay and Echo were performed. No baseline cerebral blood flow difference was found between angiographically abnormal and normal regions (49 ± 12 vs. 48 ± 11 mL/100 g/min, p = 0.44). However, baseline R2′ differed between these regions (3.2 ± 0.7 vs. 2.9 ± 0.6 s−1, p < 0.001), indicating reduced oxygenation in abnormal regions. Cerebrovascular reserve was lower in angiographically abnormal regions (21 ± 38 vs. 41 ± 26%, p = 0.001). All regions showed trend toward significantly improved oxygenation post-acetazolamide. Regions with poorer cerebrovascular reserve had lower baseline oxygenation (Kendall's τ = −0.24, p = 0.003). A number of angiographically abnormal regions demonstrated preserved cerebrovascular reserve, likely due to the presence of collaterals. Finally, of the concurrently measured relaxation rates, R2′ was superior for oxygenation assessment.